Cite

HARVARD Citation

    Lattuada, E. et al. (2018). Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life. International journal of STD & AIDS. pp. 206-207. [Online]. 
  
Back to record